SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-031170
Filing Date
2021-12-13
Accepted
2021-12-13 06:04:12
Documents
16
Period of Report
2021-12-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 34898
2 ex99-1.htm EX-99.1 43464
3 ex99-1_003.jpg GRAPHIC 10826
4 ex99-1_001.jpg GRAPHIC 131773
5 ex99-1_002.jpg GRAPHIC 356732
  Complete submission text file 0001493152-21-031170.txt   954536

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT glsi-20211209.xsd EX-101.SCH 3064
7 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT glsi-20211209_lab.xml EX-101.LAB 34916
8 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT glsi-20211209_pre.xml EX-101.PRE 22815
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3876
Mailing Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477
Business Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477 203-434-3290
Greenwich LifeSciences, Inc. (Filer) CIK: 0001799788 (see all company filings)

IRS No.: 205473709 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39555 | Film No.: 211486868
SIC: 2834 Pharmaceutical Preparations